#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy General anaesthesia Osteosarcoma metastatic Pulmonary sarcoidosis Cutaneous T-cell lymphoma Cystic fibrosis respiratory infection suppression Osteosarcoma Medulloblastoma recurrent Biotinidase deficiency Spinal muscular atrophy Insulinoma B-cell type acute leukaemia Ventricular tachycardia Congenital leptin deficiency Alternating hemiplegia of childhood More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Trials in Disease Antisynthetase syndrome – Life with Disease Lymphangiosarcoma – Life with Disease Hyperoxaluria – Treatment Propionic acidaemia – Basic Information Indolent systemic mastocytosis – Treatment Encephalitis autoimmune – Basic Information Mucous membrane pemphigoid – Diagnostics Von Willebrand’s disease – Basic Information Cytokine release syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sitravatinib Malate Fostemsavir Trometamol Clebopride Hydrogen Maleate Bleomycin Sulfate Ph. Eur. Teriparatide Abc-15A-116 Gedatolisib Vilobelimab Calcifediol Leuprorelin Acetate Fezolinetant Emrusolmin R3R01 Encorafenib Setrusumab Dimeticone Tepotinib Proguanil Hydrochloride Transcon Il-2Β/Γ Carbasalate Calcium More therapies…

    Learn about Your Condition

    Hypoalbuminaemia Chondroplasty Neonatal asphyxia Oesophageal food impaction Gout Systemic scleroderma Cerebral amyloid angiopathy Transplant rejection Prodromal Alzheimer's disease Meniscus operation Neurofibrosarcoma Osteoporosis postmenopausal H1N1 influenza Endocrine disorder Lipid metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pauls Stradins Clinical University Hospital

Pauls Stradins Clinical University Hospital

Pilsonu Iela 13, Riga, 1002, Latvia

Want to learn more about this study or check if you can participate? Contact us.

  • Long‑Term Follow‑Up of Mitomycin (UGN‑103) Treatment in Patients with Recurrent Low‑Grade Intermediate‑Risk Non‑Muscle Invasive Bladder Cancer

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Mitomycin
    Bulgaria Estonia Latvia Romania Spain

  • Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Letrozole
    • Ribociclib
    Bulgaria Croatia Czechia Latvia Poland Romania +2

  • Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Crd-4730
    Bulgaria Czechia Hungary Italy Latvia Lithuania +4

  • Study of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Czechia Germany Greece Italy Latvia +2

  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Austria Belgium Czechia Denmark France Germany +9

  • Study to evaluate the efficacy and safety of liposomal amphotericin B for patients with simple pulmonary aspergilloma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Amphotericin B
    Latvia

  • Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Propafenone Hydrochloride
    Latvia

  • Study on the Effectiveness and Safety of Masitinib and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Riluzole
    • Masitinib
    France Germany Greece Latvia Slovenia Spain +1

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Lutikizumab
    • Adalimumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3
Previous Page
1 … 3 4 5 6 7 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!